Brain water diffusion in response to transient global ischemia (12 min), reperfusion (60 min), and cardiac arrest was monitored by localized proton magnetic resonance spectroscopy. The trace of the apparent diffusion coefficient tensor (ADC Av ) was determined at high temporal resolution (10 sec) to assess the putative neuroprotective potential of oral creatine (Cr) in rats that received 2.2 g Cr-monohydrate per kg body weight per day for 10 days (n ‫؍‬ 8) relative to controls (n ‫؍‬ 9). Cr-fed rats revealed a statistically significant increase of the cerebral concentration ratio of Cr to choline-containing compounds (20%). Animal studies have linked elevated brain creatine (Cr) and phosphocreatine (PCr) to neuroprotection. For example, in hippocampal slices, the availability of Cr was shown to yield enhanced PCr levels and reduced neuronal death under hypoxic stress most likely caused by a delayed decrease of adenosine triphosphate (ATP) (1-3). Under in vivo conditions, localized magnetic resonance spectroscopy (MRS) revealed increases of total brain creatine (tCr) levels after oral supplementation of Cr-monohydrate in both rats (4-6) and humans (7). In addition, at least a partial protection of the brain against an impairment of energy metabolism was demonstrated in an animal model of Huntington's disease (5) as well as in hypoxic immature rats (6).
Animal studies have linked elevated brain creatine (Cr) and phosphocreatine (PCr) to neuroprotection. For example, in hippocampal slices, the availability of Cr was shown to yield enhanced PCr levels and reduced neuronal death under hypoxic stress most likely caused by a delayed decrease of adenosine triphosphate (ATP) (1) (2) (3) . Under in vivo conditions, localized magnetic resonance spectroscopy (MRS) revealed increases of total brain creatine (tCr) levels after oral supplementation of Cr-monohydrate in both rats (4) (5) (6) and humans (7) . In addition, at least a partial protection of the brain against an impairment of energy metabolism was demonstrated in an animal model of Huntington's disease (5) as well as in hypoxic immature rats (6) .
In a preceding proton MRS study of Cr supplementation in a rat model of transient global ischemia, the time courses of cerebral metabolite concentrations such as lactate (Lac) and glucose (Glc) revealed no differences between Cr-fed rats and controls on a time scale of minutes (4) . Complementary, diffusion-weighted MRS (8, 9) and MRI (10,11) of brain water allows monitoring of ischemia-induced alterations of the apparent diffusion coefficient (ADC) at a temporal resolution of up to 10 sec. The diffusion sensitivity is generally ascribed to the occurrence of cytotoxic cell swelling (cytotoxic edema) which results from the depolarisation of cell membranes and an osmotically driven influx of water. The underlying loss of normal cell ion homeostasis is caused by a failure of the plasma membrane ion pumps which in turn reflects the loss of ATP within regions of severely reduced blood flow (12) .
The purpose of this work was to determine whether the rapid diffusion changes following transient global ischemia and cardiac arrest are modulated or even alleviated by oral administration of Cr using high-speed determinations of the trace of the ADC tensor, i.e., ADC Av . The study was based on the hypothesis that elevated Cr/PCr levels may delay and/or attenuate the decrease of brain ATP levels and therefore stabilize the energy metabolism during the early stages of ischemia. A preliminary account has been given in abstract form (13) .
MATERIALS AND METHODS
Studies of male Wistar rats were performed in accordance with German animal-protection laws and approved by the responsible governmental authority. The Cr-fed group (n ϭ 8, 315 Ϯ 26 g) received Cr-monohydrate (Sigma Chemical Co., St. Louis, MO) in their feed at a dose of 2.23 Ϯ 0.12 g per kg body weight per day (0.5% in water, 2.0% in rodent chow) for 10 days, whereas control animals (n ϭ 9, 319 Ϯ 50 g) were on a normal diet.
Cr-fed rats and controls underwent a protocol consisting of water-suppressed localized proton MRS of cerebral metabolites and subsequent dynamic determinations of ADC Av values obtained from the unsuppressed water signal. Diffusion measurements (100 min) were performed before (10 min) and during transient global ischemia (12 min, four-vessel occlusion model), during reperfusion (60 min), and after cardiac arrest (18 min, KCl injection). Details of the experimental setup, surgical procedure, anesthesia and ventilation, reversible occlusion, and physiologic monitoring were as previously described (4) . In particular, there were no statistically significant differences in arterial P O 2 , P CO 2 , pH, mean blood pressure, and plasma Glc level between Cr-fed rats and controls (unpaired t test) or before and after ischemia (paired t test).
MR measurements were carried out at 2.35 T using a MRBR 4.7/400 mm magnet (Magnex Scientific, Abingdon, England) and a 100 mT · m Ϫ1 B-GA20 gradient system driven by ABX-11 electronics (Bruker, Karlsruhe, Germany). Radiofrequency excitation and signal reception were accomplished by a 14-cm Helmholtz coil and a 2-cm surface coil, respectively. Localized short echo-time proton MR spectra (STEAM, TR/TE/TM ϭ 6000/20/10 msec) were acquired from a 0.245 ml (7 ϫ 5 ϫ 7 mm 3 ) volume of interest (VOI) centrally placed in the cortex. Metabolite quantification involved fully automated and user-independent spectral evaluation by LCModel and calibration with respect to the brain water concentration (4).
Diffusion-weighted proton MRS (STEAM, TR/TE/ TM ϭ 1000/140/10 msec) of the water signal from the same VOI was performed at high temporal resolution (10 sec) using three pairs of nonoverlapping bipolar lobes of orthogonal gradients with the same polarity. Diffusion gradients were placed symmetrically around the TM period to ensure single-shot isotropic diffusion weighting as proposed by Mori and van Zijl (14) . The MRS implementation avoids any cross talk between localization and diffusion gradients, i.e., transverse magnetizations are fully refocused before and after the diffusion weighting periods and the effects of background gradients are automatically compensated. To minimize contributions from restricted diffusion, both the gradient duration ␦ and the diffusion time ⌬ between corresponding gradient lobes were adjusted to ␦ ϭ ⌬ ϭ 10 msec. Respirator-triggered acquisitions of brain water diffusion were based on 10 spectra with variable gradient strengths of up to 90 mT · m Ϫ1 . Pertinent measurements were obtained continuously during the entire protocol and exploited for online determinations of the trace of the diffusion tensor
from the strength of the water signal in the time domain (10-Hz line broadening) in accordance to the StejskalTanner equation
with A the measured signal strength at diffusion gradient strength G, A 0 the signal at zero gradient strength, n the number of bipolar gradient pairs (n ϭ 6), and ␥ the magnetogyric ratio. Online calculations of ADC Av values were done using a modified Levenberg-Marquard algorithm (IMSL-C Numerical Libraries Version 1.02, Visual Numerics, Inc., Houston, Texas). The ADC Av time course was continuously displayed (Gnu-Plot, version 3.5, C. Kelley, T. Williams) to confirm a successful occlusion of the carotid arteries by a corresponding ADC Av decrease. Figure 1 compares mean proton MR spectra of rat brain in vivo from Cr-fed rats and controls. The visible trends toward elevated tCr (7%) and myo-inositol (Ins, 8%) are confirmed when using concentration ratios with reference to choline-containing compounds (Cho). In line with previous findings (4), Cr-fed rats revealed statistically significant increases (unpaired t tests) of tCr/Cho (20%) and Ins/Cho (24%).
RESULTS
Mean time courses of the ADC Av in response to transient global ischemia (hashed bar), reperfusion, and cardiac arrest (black bar) are shown in Figure 2 for both Cr-fed rats and controls. The observed ADC Av reductions during ischemia (and after cardiac arrest) and its recovery during reperfusion were very similar in both groups. The slightly smaller decrease of the ischemic ADC Av value in the Cr group was statistically not significant. These findings are supported by the quantitative data summarized in Table 1 . Whereas the mean ADC Av values for Cr-fed rats and controls are almost identical before and 50-60 min after ischemia, the percentage reductions ⌬ADC Av after 12 min of ischemia and cardiac arrest are slightly less pronounced in Cr-fed rats. Details of the temporal evolution of diffusional changes are depicted in Figure 3 . In particular, the ADC Av responses to transient ischemia may be characterized by three phases (I-III) and respective transition times (t 1 , t 2 ). Phase I lasts for about 1.5 min and accounts for about 20% of the total ADC Av reduction. It consists of an initial drop within the first 20-30 sec after occlusion and a somewhat slower diffusion change thereafter. The major part of the ADC Av reduction occurs during phase II and corresponds to about 60% of the total decrease. It may be described by an exponential decay during a period of approximately 2.5 min. The almost linear ADC Av decrease during phase III starts at 3.9 min after the onset of ischemia and contributes about 20% of the total change.
To quantify the dynamic diffusion changes, the ADC Av time courses were fitted by the superposition of a monoexponential and a linear decay representing phases II and III. The transition time t 1 between phases I and II is defined by the minimum difference between the model and the diffusion data, whereas the transition time t 2 between phases II and III corresponds to the 5% level of the exponential decay. Pertinent values as well as decay time constants are summarized in Table 2 . Changes between groups were not statistically significant. However, the transition from phase I to II as well as the time constant for the major ADC Av decay during acute ischemia were slightly prolonged in the Cr-fed group (23% increase of t 1 , 10% increase of the decay time constant during phase II). This is also shown in Fig. 3 , which compares mean ADC Av time courses for Cr-fed rats and controls.
During 60 min of reperfusion ADC Av values returned to preischemic levels in all cases. In fact, recovery was completed in shorter time periods as indicated by the 90% recovery time t 90 given in Table 2 . Although the mean time courses of the ADC Av shown in Fig. 3 do not reveal major differences between Cr-fed rats and controls, they suggest a slightly faster renormalization in the Cr-fed group during early reperfusion. This observation is supported by the 50% recovery time t 50 given in Table 2 . Again, differences between both groups were not statistically significant.
DISCUSSION
Although at the expense of high spatial resolution, the use of isotropically diffusion-weighted localized proton MRS of brain water yields quantitative determinations of the trace of the diffusion tensor at high temporal resolution and with excellent signal to noise. In fact, the present data are characterized by a very low interindividual variation and correspondingly small SD ( Table 1 ). The ADC Av values before ischemia and after reperfusion are in close agreement with results reported for cat and rat brain (9) (10) (11) . Unfortunately, a more detailed comparison of absolute values as well as of changes during ischemia with literature findings is hampered by differences in diffusion times, orientation of the diffusion gradients, brain regions, and species. The temporal evolution of ADC Av changes in response to acute ischemia as well as after cardiac arrest exhibits a multiphasic behavior in agreement with previous observations by others (8-11) . Thus, the early diffusion changes may be quantified in terms of transition times and decay time constants for a model comprising three phases of pathophysiologic events. Phase I is generally assumed to reflect the early breakdown of oxidative metabolism. For example, by use of biochemical methods it has been reported that both PCr and ATP pools are depleted after approximately 90 sec of ischemia in adult rats (15) . This timing is in excellent agreement with the t 1 values obtained here (Table 2) for the transition of phase I to II. It further coincides with the timing reported for the increase of extracellular K ϩ concentrations accompanying anoxic depolarization (16, 17) . The subsequent strong ADC Av reduction during phase II (ϳ2.5 min) parallels the shift of extracellular to intracellular water after the breakdown of energy supply and ion homeostasis. During phase III, i.e., 3.9 min after the onset of ischemia, the occurrence of a further but slower ADC Av decrease must be ascribed to brain cooling leading to a continuously decreasing tissue temperature (18) .
During reperfusion ADC Av values start to increase within a few seconds after the release of the balloon occluders. This observation is consistent with the immediate inflow of warm blood into the brain and a rapid recovery of the cerebral blood oxygenation. Both effects should account for a total ADC Av increase by approximately 40% of the ⌬ADC Av value. A further increase should result from the normalisation of the K ϩ concentration, which is completed within 4-5 min (16, 17) . Typical recovery times are 1.5-1.8 min (50%) and approximately 8 min (90%), whereas full return to mean preischemic values requires 30-40 min (compare Fig. 2) . Normalisation of the cerebral PCr/ATP ratio has been reported to take approximately 24 min after a 15-min period of transient global ischemia (19) .
Although diffusion changes after cardiac arrest follow the same pattern as during acute global ischemia, they are slightly more pronounced (⌬ADC Av in Table 1 ) and faster (t 1 and t 2 in Table 2 ). This may be explained by the fact that transient ischemia-in contrast to cardiac arrest-retains beneficial effects from residual collateral blood flow and a lower degree of brain cooling as a result of the isolating effect of the perfused skull. and recovery times (t 50 , t 90 ) characterize the multiphasic diffusion changes during ischemia (and cardiac arrest) and reperfusion, respectively. In accordance with the aforementioned series of events, a putative neuroprotective role of Cr is mainly to be expected during the early phases of ischemia. Brain uptake of oral Cr is at least partially followed by phosphorylation and elevation of the cerebral PCr concentration, which may delay and/or attenuate ATP depletion during hypoxic/ischemic challenge (1-3,5,6 ). The use of high temporal resolution allowed us to identify mild trends for a prolonged phase I, a longer decay time constant during phase II (establishment of the cytotoxic edema), and a less severe total reduction of ADC Av in Cr-fed rats versus controls. Although these findings suggest a slightly better performance of the brain energy status after oral administration of Cr, larger beneficial effects are to be expected for less severe and/or focal hypoxic-ischemic challenges or in immature rats.
